Skip to content
  • Sunday, 26 July 2026
  • 2:48 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Roche and C4 Therapeutics Forge Strategic Alliance to Pioneer Degrader-Antibody Conjugates for Novel Cancer Therapies
Pharmaceutical R&D

Roche and C4 Therapeutics Forge Strategic Alliance to Pioneer Degrader-Antibody Conjugates for Novel Cancer Therapies

Teuku Ryan Apr 11, 2026 0

Roche and C4 Therapeutics Forge Strategic Alliance to Pioneer Degrader-Antibody Conjugates for Novel Cancer Therapies Roche, a global pharmaceutical giant,…

Read More
Pharmaceutical R&D

RoosterBio and MineBio Forge Exclusive Partnership to Accelerate MSC and Exosome Therapies in China

Teuku Ryan Apr 8, 2026 0

RoosterBio, a prominent innovator in the field of mesenchymal stem cell (MSC) and exosome bioprocessing, has announced an exclusive distributor…

Read More
Pharmaceutical R&D

Biocytogen and Sihuan Pharmaceutical Forge Strategic Alliance to Accelerate Advanced Therapies, Including Novel Weight Loss Treatments

Teuku Ryan Apr 3, 2026 0

The pharmaceutical landscape is poised for significant advancement as Biocytogen, a leader in antibody-based drug discovery, and Sihuan Pharmaceutical, a…

Read More
Pharmaceutical R&D

Cognito Therapeutics and Ochsner Health Forge Landmark Partnership to Advance Brain Health Innovation in the Gulf South

Teuku Ryan Mar 26, 2026 0

A groundbreaking collaboration has been established between US-based neurotechnology firm Cognito Therapeutics and Ochsner Health, a leading integrated healthcare system…

Read More
Pharmaceutical R&D

Viz.ai and Alnylam Forge Strategic Alliance to Revolutionize Cardiac Amyloidosis Diagnosis and Care

Teuku Ryan Mar 26, 2026 0

In a significant development poised to reshape the landscape of cardiovascular medicine, Viz.ai has announced a groundbreaking collaboration with Alnylam…

Read More
Pharmaceutical R&D

Monash University and ClinChoice Forge Strategic Alliance to Accelerate Therapeutic Development and Enhance Patient Access to Novel Treatments

Teuku Ryan Mar 25, 2026 0

Australia’s Monash University, a leading research institution, and ClinChoice, a global contract research organization (CRO), have formally announced a significant…

Read More

Posts pagination

1 … 3 4
McGill University Researchers Pioneer Quantum Phonon Generation Paving the Way for Sound-Based Lasers and Advanced Medical SensingRegional Bone Marrow Niches in the Skull Identified as Potent Reservoirs for Glioblastoma DefenseScience News: A Century of Illuminating the World of Science, Medicine, and TechnologyWell-characterized biospecimens assist development of cancer immunotherapies
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ